Literature DB >> 32895190

[Heparanase promotes trans-endothelial migration of hepatocarcinoma cells by inducing apoptosis of microvascular endothelial cells].

Xiaopeng Chen1, Rui Ye1, Dafei Dai1, Yuhai Wu1, Yuanlin Yu1, Bin Cheng1.   

Abstract

OBJECTIVE: To explore the effect of heparanase (HPSE) on apoptosis of microvascular endothelial cells (MVECs) and trans-endothelial migration of hepatocellular carcinoma (HCC) cells.
METHODS: A HCC cell line with high HPSE expression was selected by real-time quantitative PCR (qRT-PCR) and Western blotting and transefected with a lentiviral vector containing an interfering RNA sequence of HPSE. Transwell migration assay was performed to detect the trans-endothelial migration (TEM) rate of the transfected HCC cells across human umbilical vein endothelial cells (HUVECs). In a Transwell indirect co-culture system, the effect of HPSE silencing in the HCC cells was determined on apoptosis of HUVECs in vitro. A nude mouse model of HCC was used to verify the effect of HPSE on apoptosis of MVECs and liver metastasis of the tumor.
RESULTS: HCCLM3 cell line highly expressing HPSE was selected for the experiment. Transfection of the HCC cells with the lentiviral vector for HPSE interference the HCC cells resulted in significantly lowered TEM rate as compared with the cells transfected with the control vector (P < 0.01). In the indirect co-culture system, the survival rate of HUVECs co-cultured with HCCLM3 cells with HPSE interference was significantly higher and their apoptotic index was significantly lower than those in the control group (P < 0.05). Ultrastructural observation showed no obvious apoptosis of HUVECs co-cultured with HCCLM3 cells with HPSE interference but revealed obvious apoptotic changes in the control group. In the animal experiment, the tumor formation rate in the liver was 100% (6/6) in the control group, significantly higher than that in RNAi group (33.3%, 2/6) (P < 0.05). Under optical microscope, necrosis and apoptosis of the MVECs was detected in the liver of the control mice, while the endothelial cells remained almost intact in RNAi group.
CONCLUSIONS: HPSE promotes the metastasis of HCC cells by inducing apoptosis of MVECs.

Entities:  

Keywords:  apoptosis; heparanase; hepatocellular carcinoma; microvascular endothelial cells; trans-endothelial migration

Mesh:

Substances:

Year:  2020        PMID: 32895190      PMCID: PMC7429165          DOI: 10.12122/j.issn.1673-4254.2020.08.01

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  40 in total

1.  Suppressive effects of nonsteroidal anti-inflammatory drugs diclofenac sodium, salicylate and indomethacin on delayed rectifier K+-channel currents in murine thymocytes.

Authors:  Itsuro Kazama; Yoshio Maruyama; Yoshimichi Murata
Journal:  Immunopharmacol Immunotoxicol       Date:  2012-03-12       Impact factor: 2.730

2.  Heparanase and cancer progression: New directions, new promises.

Authors:  Gil Arvatz; Marina Weissmann; Neta Ilan; Israel Vlodavsky
Journal:  Hum Vaccin Immunother       Date:  2016-04-07       Impact factor: 3.452

3.  Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.

Authors:  I Vlodavsky; Y Friedmann; M Elkin; H Aingorn; R Atzmon; R Ishai-Michaeli; M Bitan; O Pappo; T Peretz; I Michal; L Spector; I Pecker
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

4.  Apoptotic and necrotic death mechanisms are concomitantly activated in the same cell after cerebral ischemia.

Authors:  Isin Unal-Cevik; Munire Kilinç; Alp Can; Yasemin Gürsoy-Ozdemir; Turgay Dalkara
Journal:  Stroke       Date:  2004-07-15       Impact factor: 7.914

5.  Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma.

Authors:  Bin Lv; Bin Zhang; Xiao-Yan Hu; Qing-Dong Zeng
Journal:  Oncol Lett       Date:  2016-01-08       Impact factor: 2.967

6.  Assessment of Heparanase-Mediated Angiogenesis Using Microvascular Endothelial Cells: Identification of λ-Carrageenan Derivative as a Potent Anti Angiogenic Agent.

Authors:  Nicolas Poupard; Pamela Badarou; Fabienne Fasani; Hugo Groult; Nicolas Bridiau; Frédéric Sannier; Stéphanie Bordenave-Juchereau; Claudine Kieda; Jean-Marie Piot; Catherine Grillon; Ingrid Fruitier-Arnaudin; Thierry Maugard
Journal:  Mar Drugs       Date:  2017-05-09       Impact factor: 5.118

7.  Overexpression of heparanase attenuated TGF-β-stimulated signaling in tumor cells.

Authors:  Tahira Batool; Jianping Fang; Uri Barash; Aristidis Moustakas; Israel Vlodavsky; Jin-Ping Li
Journal:  FEBS Open Bio       Date:  2017-02-11       Impact factor: 2.693

8.  The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression.

Authors:  Preeti Singh; Alexandra Blatt; Sari Feld; Yaniv Zohar; Esraa Saadi; Liza Barki-Harrington; Edward Hammond; Neta Ilan; Israel Vlodavsky; Yehuda Chowers; Elizabeth Half
Journal:  Neoplasia       Date:  2017-01-29       Impact factor: 5.715

Review 9.  Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity.

Authors:  Cinzia Lanzi; Giuliana Cassinelli
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

10.  Surveillance and diagnosis of hepatocellular carcinoma: A systematic review.

Authors:  Sonia Pascual; Cayetano Miralles; Juan M Bernabé; Javier Irurzun; Mariana Planells
Journal:  World J Clin Cases       Date:  2019-08-26       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.